Clinical Trials Logo
  1. Home
  2. Anesthesia, General
  3. NCT06205212
  4. Details
NCT06205212 Clinical Trial

High-flow Nasal Oxygenation During Preoxygenation and Atelectasis

Anesthesia, General Clinical Trial

Official title:
The Effect of High-flow Nasal Cannula Applied During Preoxygenation for Prevention of Atelectasis in Patients With Obesity Undergoing General Anesthesia: A Randomized Controlled Trial

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT06205212
Other study ID # HFNO_PRE
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 10, 2023
Est. completion date October 10, 2024

Study information
Verified date September 2023
Source Seoul National University Hospital
Contact TAE KYONG KIM
Phone 82-2-870-2519
Email ktkktk@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Atelectasis after induction of general anesthesia is common even in healthy patients and is clinically problematic, especially in obese patients. We aim to investigate whether preoxygenation with high-flow nasal oxygen during anesthesia induction reduces atelectasis in obese patients.

Recruitment information / eligibility
Status Recruiting
Enrollment 92
Est. completion date October 10, 2024
Est. primary completion date October 10, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adults patients undergoinig surgery under general anesthesia with a BMI of 30 kg/m2 or greater who have given informed consent Exclusion Criteria: - surgery time less than 2 hours - Nasotracheal intubation - Severe cardiac or respiratory disease - History of difficult airway - History of a surgery or anatomical anomaly in the head and neck - History of Inability to breathe through nose - Gastric reflux disease

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• high-flow nasal oxygen
preoxygenation using high-flow nasal oxygen, FiO2 1.0, 40 L/min, 3 min
• facemask
preoxygenation using facemask, FIO2 1.0, fresh gas flow 10 L/min, 3 min

Locations
Country Name City State
Korea, Republic of SMG - SNU Boramae Medical Center Seoul

Sponsors (2)
Lead Sponsor Collaborator
Seoul National University Hospital SMG-SNU Boramae Medical Center

Country where clinical trial is conducted

Korea, Republic of, 

Outcome
Type Measure Description Time frame Safety issue
Primary Lung ultrasound score modified LUSS Immediately after anesthesia induction
Secondary Incidence of atelectasis Immediately after anesthesia induction
Secondary PaO2 to FiO2 ratio and PaCO2 Immediately after anesthesia induction
Secondary Hemodynamic variables Blood pressure, heart rate, pulse oximetry During anesthesia induction
Secondary Patient Satisfaction Score During preoxygenation
Secondary Lung ultrasound score In the PACU after surgery
Secondary Incidence of Spo2 less than 95% during 48 hours postoperatively
Secondary Maximum body temperature during hospitalization up to 1 week
Secondary Incidence of postoperative pulmonary complications during hospitalization up to 1 week
Secondary length of hospital stay up to 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT06063798 - Respiratory Effects of Flow-Controlled Ventilation and Jet Ventilation in Patients Undergoing Laryngotracheal Surgery N/A
Not yet recruiting NCT05035069 - Efficacy and Safety of Ciprofol Compared to Propofol for Nonintubated General Anesthesia in Patients Undergoing TAVR Phase 4
Completed NCT03861364 - Hemodynamics During Induction of General Anesthesia With High and Low Propofol Dose. Phase 4
Completed NCT02711280 - The Effect of Anesthetics on Oxidative Stress and Apoptosis Status in Children N/A
Completed NCT01199471 - Estimate the Behavior of Chinese Anesthesiologists Practicing General Anesthesia With Sevoflurane N/A
Completed NCT00917033 - Tracheal Intubation of Morbidly Obese Patients. GlideScope Versus Direct Laryngoscopy Phase 4
Completed NCT00391885 - Target-controlled Infusion of Propofol and Remifentanil During General Anaesthesia Guided by Entropy Phase 4
Completed NCT00552617 - A Bridging Trial Comparing Sugammadex (Org 25969) at Reappearance of T2 in Japanese and Caucasian Participants. Part B: Caucasian Participants (P05971) Phase 2
Completed NCT03705026 - Relationship Between Genetic Polymorphism and Postoperative Nausea and Vomiting in Chinese Han Population
Completed NCT00552929 - A Bridging Trial Comparing Sugammadex (Org 25969) at 1-2 Post-Tetanic Count (PTC) in Caucasian Participants. Part B (P05974) Phase 2
Completed NCT00475215 - Safety and Efficacy of Sugammadex (Org 25969, MK-8616) in Participants With or Having a Past History of Pulmonary Disease (19.4.308) (P05932) (MK-8616-017) Phase 3
Completed NCT00298831 - Use of Sugammadex at the End of Case in Routine Anesthesia (MK-8616-023) Phase 3
Recruiting NCT03943745 - EEG Changes During Induction of Propofol Anesthesia
Completed NCT03697642 - Nasopharyngeal Airway Guide Nasogastric Tube Placement N/A
Completed NCT04595591 - Observation of Propofol Titration at Different Speeds N/A
Not yet recruiting NCT05841316 - The ED95 Dose of Sugammadex to Reverse Rocuronium-Induced Deep Neuromuscular Block Back to Shallow Neuromuscular Block
Completed NCT04532502 - Impact of Anesthetic Environment the Sex Ratio of the Children of Female Assistants
Completed NCT03330236 - EEG - Guided Anesthetic Care and Postoperative Delirium N/A
Completed NCT00379613 - Use of Sugammadex Administered at 5 Minutes After Administration of 1.2 mg/kg Esmeron® (19.4.205)(P05942) Phase 2
Completed NCT03841890 - The Clarus Video System and Direct Laryngoscope for Rapid Sequence Induction Intubation With Cricoid Pressure N/A